Medical technology company specializing in particle therapy and dosimetry for cancer treatment.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about IBA S.A..
The 1 sources with the most insights about IBA S.A. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
The speaker said he was short a small amount, citing prior unsuccessful attempts to use the same mechanism in the disease.
The speaker said he was short a small amount, citing prior unsuccessful attempts to use the same mechanism in the disease.
Other assets that creators frequently mention in the same content as IBA S.A..
The most active sources covering IBA S.A. (IBAB) on Kazuha are @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about IBA S.A. (IBAB) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering IBA S.A. (IBAB) most frequently also discuss DUPIXENT, DELL, ASML, BTC, LQDA. See the "Discussed alongside" section above for full asset pages.